Department of Neurology, University of California-Irvine, Irvine, CA, U.S.A.
Department of Neurology, John Peter Smith Health Network, Fort Worth, TX, U.S.A.
Anticancer Res. 2020 Jun;40(6):3453-3457. doi: 10.21873/anticanres.14331.
BACKGROUND/AIM: Gliomas present a uniquely challenging clinical situation in the context of pregnancy, with no standard recommendations. This case series aimed to describe the treatment regimen and outcomes of five pregnant patients with gliomas.
This is a retrospective study. A patient database from electronic medical records was evaluated to identify pregnant patients with gliomas treated at our institution between 2008-2018.
Five study patients who were pregnant with gliomas were identified. Of these, 4 were diagnosed during pregnancy, while 1 was diagnosed prior to her pregnancy. One patient had grade 2 astrocytoma, 1 had grade 3 anaplastic astrocytoma, and 3 had grade 4 glioblastomas (GBM). All patients received surgery, and one patient received radiation therapy without concurrent chemotherapy during her pregnancy. All delivered healthy babies. Three of the 5 patients remain alive, and 2 of the 5 were progression-free at the last follow-up.
Treatment plans must be specifically tailored to the individual patient based on the glioma grade, the mother's desire to continue the pregnancy, and the risks of delaying treatment until after pregnancy. Additional studies need to be performed to definitively establish uniform guidelines for the treatment of pregnant patients with glioma.
背景/目的:在妊娠背景下,神经胶质瘤的表现具有独特的挑战性,目前尚无标准建议。本病例系列旨在描述 5 例妊娠合并神经胶质瘤患者的治疗方案和结局。
这是一项回顾性研究。从电子病历的患者数据库中评估了在我们机构治疗的妊娠合并神经胶质瘤的患者。
共确定了 5 例妊娠合并神经胶质瘤的研究患者。其中,4 例在妊娠期间诊断,1 例在妊娠前诊断。1 例患者患有 2 级星形细胞瘤,1 例患有 3 级间变性星形细胞瘤,3 例患有 4 级胶质母细胞瘤(GBM)。所有患者均接受了手术治疗,其中 1 例患者在妊娠期间接受了未联合化疗的放射治疗。所有患者均产下了健康的婴儿。5 例患者中有 3 例存活,5 例患者中有 2 例在最后一次随访时无进展。
必须根据神经胶质瘤分级、母亲继续妊娠的意愿以及延迟治疗直至妊娠后带来的风险,为每位患者制定具体的治疗方案。需要进一步开展研究,以明确制定治疗妊娠合并神经胶质瘤患者的统一指南。